Table 4 |
|||||
|
Antimicrobial susceptibilities of Gram-negative microorganisms isolated from infections in ICU. |
|||||
|
Percentage (%) of isolates resistant to antimicrobial by broth microdilution |
|||||
|
|
|||||
|
Antimicrobial |
P. aeruginosa n = 157 |
A. baumannii n = 74 |
Enterobacter spp n = 32 |
K. pneumoniae n = 25 |
E. coli n = 38 |
|
|
|||||
|
Amikacin |
29.9% |
71.6% |
59.4% |
16% |
18.4% |
|
Azteronam |
77.1% |
94.6% |
81.2% |
88% |
86.8% |
|
Piperacillin |
69.4% |
100% |
71.8% |
76% |
68.4% |
|
Ticarcillin |
93% |
93.2% |
81.2% |
64% |
68.4% |
|
Ceftriaxone |
98.1% |
100% |
59.4% |
84% |
84.2% |
|
Cefotaxime |
96.2% |
100% |
59.4% |
84% |
84.2% |
|
Ceftazidime |
71.3% |
100% |
75% |
88% |
86.8% |
|
Ciprofloxacin |
59.2% |
56.7% |
0% |
20% |
39.5% |
|
Imipenem |
26.1% |
63.5% |
0% |
12% |
13.1% |
|
Cefoperazone |
93% |
100% |
62.5% |
72% |
86.8% |
|
Gentamicin |
48.4% |
85.1% |
81.2% |
80% |
78.9% |
|
|
|||||
|
Bayram and Balci BMC Infectious Diseases 2006 6:155 doi:10.1186/1471-2334-6-155 |
|||||